Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 5, 2019

French patients who suffer from pain not treated by other medicines will be eligible, and the committee is looking for anyone in palliative care, epilepsy patients, and those suffering from the side effects of chemotherapy. Patients with muscle spasms related to multiple sclerosis are also invited to take part. billion ($3.2

Medicine 60

Medicine Patients Digestion Epilepsy 60

Veriheal

APRIL 11, 2024

million registered in 2020 and an even more dramatic rise from the 678,000 registered in 2016. This data aligns with Americans’ rising acceptance of cannabis. million patients in 2022, a sharp increase from the 3.1

Patients 108

Patients Chronic Pain Marijuana Conditions 108

Veriheal

NOVEMBER 22, 2021

Have you ever wondered who spends more on cannabis: those who consume recreationally or for medicinal purposes? Headset , a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting. Well, we’ve got answers.

Recreational 98

Recreational Data Dispensary Cannabis 98

Veriheal

FEBRUARY 3, 2021

The study published in the Annals of Internal Medicine found that there is an increasing number of cannabis consumption by adults over the age of 55. . As you can see, researchers and scientists are providing individuals with the necessary data to reverse propaganda and to negate stereotypes of cannabis consumers.

Consumption 52

Consumption Safety THC Cannabis 52

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Study Findings.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 244

Clinical Trials Chronic Pain Cannabinoids Patients 244

Cannabis Law Report

OCTOBER 30, 2019

Despite strong prescription growth in Australia and inroads in many jurisdictions abroad, not to mention recreational cannabis legalisation in Canberra which paradoxically may be a threat to the sector , weak investor sentiment has been a tough pill to swallow for medicinal cannabis companies on the ASX. million. .

Medicine 45

Medicine Wellness and Beauty Research and Development Patients 45

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Veriheal

JULY 12, 2021

According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. A 2020 study reported that the top conditions reported amongst veterans include chronic pain , sleep problems , anxiety , and depression.

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

FEBRUARY 6, 2020

A controversial bill that would have banned high-potency concentrates in Washington state was resoundingly rejected for the 2020 session. Washington’s well-publicized “10 percent concentrates bill” has been stopped in committee for the 2020 session.

Concentrates 115

Concentrates Data THC Medicine 115

The Cannigma

JUNE 13, 2021

It is possible that when used for medicinal purposes and with low-THC strains that are less likely to lead to CUD, cannabis may not have a negative impact on sleep,” the researchers stated. The earlier female participants reported first using cannabis, the more likely they are to have self-reported sleep issues, the researchers found.

Sleep 137

Sleep Data Cannabis THC 137

Veriheal

JANUARY 7, 2022

The report is based on a review of 17 studies from 2013 to 2020—encapsulating nearly 200,000 responses—that involve adolescents from the U.S. Based on the study’s data, the use of cannabis among 12th graders over the last several years has consistently remained around the 35% mark. and Canada. for medical purposes.

Vaping 98

Vaping Education Data Consumption 98

Veriheal

DECEMBER 9, 2022

In fact, over 564,000 Americans died from overdoses related to prescription and illicit opiates between 1999 and 2020. This new stud y looked at insurance claim data from 2012-2017 for 38,189 individuals who had been diagnosed with cancer. This new study comes courtesy of the peer-reviewed journal Clinical Toxicology.

Patients 96

Patients Cannabis Data Legalization 96

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. “(Cannabis is) also used in conjunction with other medicines, either to improve their efficacy or to mitigate negative side effects. by the year 2027 , at which point the market could be worth a staggering $33.2

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

MAY 21, 2022

New record for Portugal : in 2021 cannabis exports increased by 600% compared to 2020 and for 2022 the forecasts are rosy. . If in 2020 Portugal had sold 4.5 Cannabis Therapeutica. Today, therefore, in the European panorama together with France, the United Kingdom and Germany, there is a new protagonist of the five-pointed market.

Decriminalization 52

Decriminalization Cultivation Data Cannabis 52

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. 9:46 AM – Mar 19, 2020.

THC 59

THC Clinical Trials Data Consumption 59

Cannabis Law Report

FEBRUARY 14, 2020

million projected after the legalization of cannabis cultivation and sales for medicinal purposes in December 2018. Saint Vincent Targets Cannabis Industry Development in 2020 Economic Plan. million in tax revenue and licensing fees in 2019, far outpacing the US $1.8 Only US $2.2 Read full article.

Banking 59

Banking Medicine Data Cultivation 59

SpeedWeed

MAY 21, 2021

The overwhelming majority of United States clinicians believe cannabis has medicinal value, according to a new survey released last month. Clinicians who believed cannabis had medicinal uses had 5.9 Overwhelming majorities of patients and their providers acknowledge that cannabis is a legitimate medicine.

Medicine 52

Medicine Patients Policy Conditions 52

Cannabis Law Report

NOVEMBER 2, 2021

Since NORML issued the previous edition of this report in 2017, scientists have published thousands of studies relevant to the medicinal properties of cannabis. Despite claims by some that marijuana has yet to be subject to adequate scientific scrutiny, scientific interest in cannabis has increased exponentially in recent years.

Safety 52

Safety Patients Chronic Pain Advocacy 52

Cannabis Law Report

AUGUST 19, 2021

billion in 2020. The rising demand for hemp from the pharmaceutical industry, owing to the medicinal properties of the hemp fibre and hemp seed oil is likely to aid the market further in the forecast period. 12 Trade Data Analysis (HS Code: 5302). The global industrial hemp market attained a value of USD 4.7 billion by 2026.

Hemp 98

Hemp Research and Development Pharmaceutical Data 98

Veriheal

JUNE 6, 2023

Although marijuana is increasingly being decriminalized, available data reveals that it is not performance-enhancing with respect to speed, power, or strength. In fact, anxiety, depression, pain, and sleep are the most common reasons why adults use cannabis medicinally. states, it is believed that it shouldn’t be banned for athletes.

THC 98

THC Recreational Decriminalization Sleep 98

Cannabis Law Report

AUGUST 2, 2021

The net loss for the quarter increased from $1 million in 2020 to $1.7 The total revenue for the quarter was $3.7 million, which dropped from last year’s $4.9 million for the same time period. It was flat from the first quarter’s revenue of $3.8 million in 2021. million during the fiscal second quarter, representing a decrease of 23% from $3.5

Research and Development 111

Research and Development Data Access Medicine 111

SpeedWeed

AUGUST 14, 2021

The Virginia Commonwealth University of Massey Cancer Center (VCU) published a study in the journal Cancer on August 13, entitled “Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample,” which analyzed data from 19,055 people over a four-year period. professor of internal medicine at VCU.

Patients 52

Patients Data Collective Medicine 52

SpeedWeed

AUGUST 31, 2021

16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. 5, 2020, according to the department’s second annual report of the Missouri Medical Marijuana Regulatory Program. Missouri, by comparison, had 69,387 registered patients as of December 2020.

Programs 72

Programs Patients Dispensary Cultivation 72

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Cannabis Law Report

SEPTEMBER 21, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has published its latest paper in the medical journal Frontiers in Psychiatry , examining the benefits of medicinal cannabis products for individuals with anxiety and depression.

CBD 52

CBD Data Therapy Sleep 52

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We The study abstract is available here.

Safety 52

Safety Hemp Research and Development Data 52

SpeedWeed

MAY 25, 2021

Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 View original article.

Chronic Pain 52

Chronic Pain Marijuana Data Programs 52

Cannabis Law Report

AUGUST 2, 2021

In 2020, founders Daniel Goldberg , Tim Schlidt and Tony Eisenberg partnered to form Palo Santo, and formally launched the venture capital fund in 2021. Having seen the enormous therapeutic potential of psychedelic medicines years ago, the partners have been active as early participants and investors in the emerging industry.

Research and Development 98

Research and Development Therapy Collective Treatment 98

Veriheal

DECEMBER 9, 2021

Recently, a team of researchers from Case Western Reserve University School of Medicine, Yale Law School, Cato Institute, Reason Foundation, and others decided to investigate the matter. In fact, there was a study that found a decrease in adolescent cannabis consumption in 2020. Support From Other Studies.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Veriheal

APRIL 26, 2022

In 2020, legal cannabis constituted a $12.8 This currency exchange data is provided as a means of assisting industry leaders in making informed business-related decisions. COVID-19 has also posed major problems for other global supply chains, mainly due to the supply shockwave that erupted in China in February of 2020.

Supply Chain 97

Supply Chain Legalization Research and Development Chronic Pain 97

Veriheal

DECEMBER 15, 2021

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation.

Sleep 98

Sleep Cannabinoids Therapy Treatment 98

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. from 2020 to 2030 and generate revenue of $151.7 1 Global Chronic Pain Treatment Market Analysis and Growth Forecast Report 2020 – 2030.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

SpeedWeed

APRIL 3, 2021

A new survey out of Texas reveals that, according to the data they gathered, 61 percent of the state’s medical cannabis users turn to medical cannabis as a replacement for prescription drugs. . The survey was conducted online between August 11, 2020, and October 6, 2020, and recruited participants through medical cannabis patient networks.

Patients 52

Patients Chronic Pain Policy History 52

Puff Puff Post

MARCH 10, 2020

With enrollment completed, treatment is expected to conclude towards the end of March and results are anticipated to be announced in the second half of calendar 2020. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We The study abstract is available here.

Safety 52

Safety Hemp Research and Development Data 52